W H BECKENHAUER
Overview
Explore the profile of W H BECKENHAUER including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerber J, INGERSOLL J, Gast A, Christianson K, Selzer N, Landon R, et al.
Vaccine
. 1990 Dec;
8(6):536-42.
PMID: 2087874
Cats vaccinated intranasally (i.n.) with a temperature sensitive feline infectious peritonitis virus (ts-FIPV) vaccine were protected against an FIP-inducing challenge. Seventeen of 20 vaccinated cats (85%) survived a rigorous virulent...
2.
Haffer K, Koertje W, Derr J, BECKENHAUER W
Vaccine
. 1990 Feb;
8(1):12-6.
PMID: 2156386
An inactivated feline leukaemia vaccine was tested to determine if process improvements would permit it to be effectively used in a two-dose primary regimen versus the three-dose regimen required for...
3.
Gerber J, Pfeiffer N, INGERSOLL J, Christianson K, Landon R, Selzer N, et al.
Adv Exp Med Biol
. 1990 Jan;
276:481-9.
PMID: 1966441
Intranasal administration of a ts-FIPV vaccine protected cats against two rigorous challenges of immunity. Investigations showed that ts-FIP viral RNA synthesis was normal at 39 degrees C and structural proteins...
4.
Mellencamp M, Pfeiffer N, Suiter B, Harness J, BECKENHAUER W
J Clin Microbiol
. 1989 Oct;
27(10):2208-13.
PMID: 2555390
A monoclonal antibody specific for the gI glycoprotein of virulent pseudorabies virus was produced and used to affinity purify gI glycoprotein. The purified gI was used in an enzyme-linked immunosorbent...
5.
Talens L, BECKENHAUER W, Thurber E, Cooley A, Schultz R
J Am Vet Med Assoc
. 1989 May;
194(9):1273-80.
PMID: 2542202
Efficacy and safety of components of an IM-administered vaccine for prevention of infectious bovine rhinotracheitis virus (IBRV), parainfluenza type-3 (PI-3) virus, bovine viral diarrhea virus (BVDV), and respiratory syncytial virus...
6.
Gerber J, Selzer N, Sharpee R, BECKENHAUER W
Vet Immunol Immunopathol
. 1988 Feb;
18(1):41-52.
PMID: 3376421
An adjuvanted Moraxella bovis bacterin containing attachment antigens and cornea-degrading enzyme antigens protected cattle from infectious bovine keratoconjunctivitis (IBK) when experimentally challenged with homologous and heterologous challenge cultures of M....
7.
Haffer K, Sharpee R, BECKENHAUER W
Vaccine
. 1987 Jun;
5(2):133-5.
PMID: 3037814
Seventeen cats, which were previously vaccinated with a subunit, feline leukaemia vaccine (Leukocell) and subsequently challenged with virulent feline leukaemia virus (FeLV), were tested at 2 to 4 years postchallenge...
8.
Brown A, Shields T, Peetz R, Mellencamp M, BECKENHAUER W
Dev Biol Stand
. 1986 Jan;
64:53-61.
PMID: 2878847
Quantitative enzyme-linked antibody centrifuge (ELAC) assays have been developed for measuring Escherichia coli adhesion pilus antigens K99, K88, 987P and F41 in E. coli bacterins used for protecting newborn animals...
9.
Gerber J, Sharpee R, Swieczkowski T, BECKENHAUER W
Vet Immunol Immunopathol
. 1985 May;
9(1):13-22.
PMID: 4024449
Peripheral blood lymphocytes (PBL) from non-vaccinated dogs and from dogs either vaccinated intramuscularly (IM) or subcutaneously (SC) with an inactivated rabies virus vaccine (Rabguard-TC, Norden Laboratories, Lincoln, NE) or intramuscularly...
10.
BECKENHAUER W, Gill M
J Am Vet Med Assoc
. 1983 Aug;
183(4):389-90.
PMID: 6618962
No abstract available.